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COMMENTARIES
Cloning Matters: How Lawrence v. Texas Protects
Therapeutic Research
Steven Goldberg, J.D.*
Several states have banned therapeutic cloning,1 and the federal
government is considering legislation that would do the same.2 Some of
* Professor of Law, Georgetown University Law Center. I would like to thank
Lawrence Gostin for his helpful suggestions.
1. See, e.g., N.D. CENT. CODE 12.1-39-02.02(1)(c) (2003) ("A person may not...
receive the product of a human cloning for any purpose.. ."). Human cloning is defined as
"human asexual reproduction, accomplished by introducing the genetic material of a
human somatic cell into a fertilized or unfertilized oocyte, the nucleus of which has been or
will be removed or inactivated, to produce a living organism with a human or
predominantly human genetic constitution." Id. §12.1-39-01. Similar bans are achieved by
ARK. CODE ANN. §§ 20-16-1001 to 20-16-1003 (2003) and IOWA CODE ANN. §§707b.1 to
707b.4 (2003). All of these statutes ban both reproductive and therapeutic cloning. On
the distinction between reproductive and therapeutic cloning, see infra Part I.
2. Human Cloning Prohibition Act of 2003, H.R. 534, 108th Cong. § 302(a)(1) (1st
Sess. 2003) ("It shall be unlawful for any person .. to perform or attempt to perform
human cloning.... ."); see also id. § 302(a) (3) ("It shall be unlawful for any person... to...
receive for any purpose an embryo produced by human cloning or any product derived
from such embryo."). The legislation also imposes a maximum penalty of ten years
imprisonment for violations of these sections. Id. § 302(c) (1). As the text makes clear, this
bill would ban human cloning whether supported by private or public funds. The federal
legislation defines "human cloning" in language similar to that used by state legislatures:
"Human cloning" is defined as "human asexual reproduction, accomplished by introducing
nuclear material from one or more human somatic cells into a fertilized or unfertilized
oocyte whose nuclear material has been removed or inactivated so as to produce a living
organism (at any state of development) that is genetically virtually identical to an existing or
previously existing human organism." Id. § 301(1). This bill passed the House of
1
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these laws, including the proposed federal legislation, make it a crime not
only to engage in therapeutic research on a cloned embryo, but also for a
patient to use any medicine derived from such research, even if the
cloning took place in a country where the research is lawful.3 Under the
United States Constitution, government action restricting freedom in this
way must have at least a rational basis if it is to be upheld in court.
4
Opponents of therapeutic cloning argue not that medicines derived
from therapeutic cloning will be unsafe or ineffective, but rather that the
embryonic stem cells used in therapeutic cloning represent potential life
that must be protected.5 I will argue, however, that this concern is not the
real reason most individuals oppose therapeutic cloning. Indeed, this
Representatives on February 27, 2003, but it has not passed the Senate. Bill Summary and
Status for the 108th Congress, at http://thomas.loc.gov/cgi-
bin/bdquery/z?d108:HR00534:@@@L&
summ2=m& (last visited Apr. 2, 2004); see The Good Kind of Cloning, L.A. TIMES, March 12,
2003, at 2-12. Because this bill would make it unlawful to perform human cloning for any
purpose or to receive an embryo produced by human cloning for any purpose, it would ban
both reproductive and therapeutic cloning. Denise Grady, Debate over Cloning in U.S.
Remains Intense, N.Y. TIMES, February 12, 2004, at B12. For more on the two types of cloning,
see infra Part I.
3. Human Cloning Prohibition Act of 2003, H.R. 534, 108th Cong. § 302(b)-(c)(1)
(1st sess. 2003) ("It shall be unlawful for any person... to import for any purpose an
embryo produced by human cloning or any product derived from such embryo.... Any
person ... that violates this section shall be... imprisoned not more than 10 years.... ").
As this text makes clear, there is no exclusion for products received from countries where
therapeutic cloning is lawful. See, e.g., Ellen Goodman, Outlawing Science, WASH. POST,
March 8, 2003, at A23. Similarly, under North Dakota law, a person may not "receive the
product of a human cloning for any purpose." See N.D. CENT. CODE §§ 12.1-39.01 to 12.1-39-
02.02(1) (c) (2003).
4. Both the Due Process and the Equal Protection Clauses require, at a minimum, that
legislative classifications be supported by a rational basis. See, e.g., Williamson v. Lee Optical,
348 U.S. 483 (1955); Carolene Products Co. v. United States, 323 U.S. 18 (1944); see also
Robert A. Schapiro & William W. Buzbee, Unidimensional Federalism: Power and Perspective in
Commerce Clause Adjudication, 88 CORNELL L. REv. 1199, 1255 (2003). The Supreme Court is
generally quite deferential to the legislature in applying this standard. Id. At times, however,
legislative enactments have been struck down as irrational. See, e.g., Cleburne v. Cleburne
Living Ctr., 473 U.S. 432 (1985) (holding that it is irrational for the state to require a
residence for the mentally disabled to obtain a special use permit not generally required).
In Part III, I will discuss this rational basis review standard in the context of legislation
concerning cloning.
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"potential life" argument is ignored daily when some spare embryos
produced as a byproduct of routine fertility treatments are destroyed while
others are used for research.' As I will argue below, this disparate
treatment reveals that the real basis for the ban on therapeutic cloning is
repugnance at the idea of cloning, driven by a sense that cloning is
unnatural. I will conclude this Commentary by arguing that the Supreme
Court's recent decision in Lawrence v. Texas casts serious doubt on the idea
that repugnance alone is an adequate basis for a criminal statute.
I. THERAPEUTIC CLONING: SOME BACKGROUND
To understand the dispute over therapeutic cloning, it is necessary to
understand the scientific terminology that underlies the debate. The term
"human cloning" has come to include two distinct activities-reproductive
cloning and therapeutic cloning-that begin in the same way: Nuclear
material is removed from a woman's egg, and nuclear material from a
donor's somatic cells is introduced in its place.7 The egg then begins to
develop in the same manner as a traditional fertilized ovum.
In the context of reproductive cloning, this embryo would be
implanted in a uterus and brought to term. No one knows if this
procedure will work in humans, and there is real concern that any human
born in this way will be severely disabled.8 The latter concern justifies
regulation of reproductive cloning, much as the possibility of birth defects
justifies the regulation of thalidomide.!'
With therapeutic cloning, there is no intention of bringing the embryo
to term. After a few weeks, the stem cells are removed for research, with
the hope that this research will contribute to progress in the development
of treatments for individuals suffering from diabetes, Alzheimer's, and
6. See infra Part II.
7. The description of reproductive and therapeutic cloning provided in this Part is
based on Suzanne H. Rhodes, Comment, The Difficulty of Regulating Reproductive and
Therapeutic Cloning: Can the United States Learn Anything from the Laws of Other Countries?, 21
PENN. ST. INT'L L. REv. 341, 343 (2003).
8. Id. at 356-57; see also Coby S. Nixon, Note, Human Cloning and the Commerce Power: In
Light of United States v. Lopez, Congress Can-But Should Not-Regulate Human Cloning, 37
GA. L. REv. 295, 306 (2002).
9. See, e.g., Ruth Lynn Deech, Clones, Ethics and Infertility or Sex, Sheep and Statutes, 2
QUINNIPIAC HEALTH L.J. 117, 127-28 (1998-1999). The state statutes and the proposed
federal statute under consideration in this Commentary all ban reproductive cloning. See
supra notes 1-2.
3
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other ailments. ° On February 12, 2004, South Korean scientists announced
that they had derived stem cells from a cloned human embryo, moving the
promise of therapeutic cloning closer to reality." While research remains
to be done, Dr. Hwang Wee Suk, the leader of the South Korean team, is
motivated by the possibility that such research will benefit patients,
particularly by improving cell regeneration therapy.12 His efforts were
inspired in part by a newlywed couple he met at a Seoul hospital. During
their honeymoon the husband fell, severely damaging his spine; Hwang
believed the husband "was badly in need of treatment which human
embryo research could help provide." 3 In the United States, in the wake of
the Korean breakthrough, Dr. Ron McKay, a stem cell scientist at the
National Institute of Neurological Disorders and Stroke, reported that it
was now easier than previously thought to extract stem cells from cloned
human embryos. 14 McKay illustrated the potential benefits when he spoke
of a scientist "who had died in her 40's from breast cancer"; he noted that
if her tissues had been cloned to make human embryonic stem cells, those
stem cells could have then been used in cancer research.
5
II. POSSIBLEJUSTIFICATIONS FOR BANNING THERAPEUTIC CLONING
What is the justification for banning therapeutic cloning? The
legislation cannot be justified on the ground that it seeks to prohibit
unsafe or ineffective treatments, as the bans are not tailored in this way.
Under the existing state laws 6 and the proposed federal law, the use of
medicines derived from such cloning is a crime, even if the medicines are
proven to be safe and effective. Indeed, under the proposed federal law,
the importation of such medicine from any jurisdiction that permits
10. Michael J. Sandel, The Anti-Cloning Conundrum, N.Y. TIMES, May 28, 2003, at A19.
Some researchers believe that stem cells from cloned embryos will have more therapeutic
promise than stem cells from embryos that come from fertilization because using "material
cloned from a patient's own DNA... might reduce or eliminate immune response
problems." Roger H. Taylor, The Fear of Drawing the Line at Cloning, 9 B.U. J. ScI. & TECH. L.
379, 383 (2003).
11. Rick Weiss, Mature Human Embryos Cloned, WASH. POST, Feb. 12, 2004, at A01.
12. Anthony Faiola, Dr. Clone: Creating Life or Trying To Save It , WASH. POST, Feb. 29,
2004, at A01.
13. Id.
14. Gina Kolata, Cloning Creates Human Embryos, N.Y. TIMES, Feb. 12, 2004, at Al.
15. Id.
16. See supra note 1.
17. See supra note 2.
IV:2 (2004)
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therapeutic cloning, such as the United Kingdom, is also a crime
punishable by up to ten years in prison."'
Do individuals have a right to use potentially life-saving medicine
unless the government has a rational basis for prohibiting its use? I believe
that they do. In at least a few cases, the United States Supreme Court has
protected the rights of patients to control their health. For example, when
the Supreme Court, in Vacco v. Quill,'9 rejected a constitutional right to
assisted suicide, every justice on the Court affirmed a patient's right to
receive medicine to relieve pain, even if such treatment would hasten the
individual's death. Justice Rehnquist, in his opinion for the Court,
distinguished sharply between a doctor who assists a suicide and one who
provides "aggressive palliative care., 20 He further noted, "[I]n some cases,
painkilling drugs may hasten a patient's death, but the physician's purpose
and intent is, or may be, only to ease his patient's pain.",2' The concurring
opinions reiterated the right to pain relief. Justice O'Connor stressed that
"[t] here is no dispute that dying patients in Washington and New York can
obtain palliative care, even when doing so would hasten their deaths."
Justice Stevens, noting that the Supreme Court had previously upheld a
right to refuse treatment,23 wrote that "[a]voiding intolerable pain" was
also a vital liberty interest.24 Justice Souter drew precisely the same
distinction between "assistance to suicide, which is banned, and practices
such as termination of artificial life support and death-hastening pain
18. Human Cloning Prohibition Act of 2003, H.R. 534, 108 'h cong. § 302 (b)-(c) (1) (1'
sess. 2003) ("It shall be unlawful for any person... to import for any purpose... any
product derived from such embryo .... Any person ... that violates this section shall be...
imprisoned not more than 10 years.... ."); see also Ellen Goodman, Outlawing Science, WASH.
POST, March 8, 2003, at A23. On the legality of therapeutic cloning in the United Kingdom,
see Nicholas Wade, Stem Cell Studies Advance in Britain, N.Y. TIMES, Aug. 14, 2001, at Al.
19. 521 U.S. 793 (1997) (holding that the Equal Protection Clause does not create a
right to assisted suicide).
20. Id. at 802.
21. Id.
22. Id. at 737-38 (O'Connor, J., concurring). Justices Ginsburg and Breyerjoined in this
portion of O'Connor's concurrence. Id. at 736.
23. Id. at 742 (Stevens, J., concurring in the judgments). Justice Stevens explained, "In
Cruzan v. Director, Mo. Dept. of Health... the Court assumed that the interest in liberty
protected by the Fourteenth Amendment encompassed the right of a terminally ill patient
to direct the withdrawal of life-sustaining treatment." Id. at 742. Stevens also noted, "The
Cruzan case demonstrated that some state intrusions on the right to decide how death will
be encountered are ... intolerable." Id. at 745.
24. Id.
5
Goldberg: Cloning Matters: How Lawrence v. Texas Protects Therapeutic Research
Published by Yale Law School Legal Scholarship Repository, 2004
YALE JOURNAL OF HEALTH POLICY, LAW, AND ETHICS
medication, which are permitted. 2 5
If the government cannot arbitrarily deny an individual access to
death-hastening pain medication, it is at least arguable that it cannot deny
access to potentially life-saving medicine without a rationale. Of course, the
absence of a valid reason to ban pain medication does not, in itself,
demonstrate that there is no rationale for banning therapeutic cloning. I
will discuss below the rationales that have been offered for such a ban.2 6
The Vacco case simply supports the plausible proposition that the
government cannot arbitrarily ban therapeutic cloning.
Nor does Vacco stand alone. For example, the Court has held that the
state cannot arbitrarily forbid a woman from choosing an abortion
procedure, even one that would otherwise be illegal, when it is necessary to
protect her health. 7 This suggests yet again that the Court will ask for a
rational justification when the government bans a safe and effective
medicine derived from therapeutic cloning.
This means, of course, that it is important to determine whether a
rational basis exists for such a ban. To do this, it is necessary to consider
what possible justifications exist for the criminalization of therapeutic
cloning. Several commentators have suggested that allowing therapeutic
cloning increases the likelihood that we will someday come to accept
reproductive cloning, and that this provides sufficient justification for the
ban.28 But our government does not have a free hand to regulate lawful
activities because they might someday lead to unlawful ones. Otherwise
little would be free from government regulation. Abortion cannot be
banned because it might bring about the acceptance of infanticide. As the
25. Id. at 809-10 (Souter,J., concurring in the judgment).
26. See infra notes 28-33 and accompanying text.
27. Stenberg v. Carhart, 530 U.S. 914, 936-38 (2000) (holding that the state cannot ban
"a particular abortion procedure" without a health exception for the mother when this
procedure may at times be the safest for the mother). Another indication that the Court
gives weight to an individual's right to receive medicine is provided in the prison context.
See Estelle v. Gamble, 429 U.S. 97, 103-04 (1976) (holding that the government must
provide medical care for those it incarcerates).
28. See, e.g., Janet L. Dolgin, Embryonic Discourse: Abortion, Stem Cells, and Cloning, 31 FLA.
ST. U. L. REv. 101, 112, 148 (2003); Cass R. Sunstein, Is There a Constitutional Right To Clone?,
53 HASTINGS L.J. 987, 1004 (2002). It is hard to see how this justifies the ban on importing
medicines produced by therapeutic cloning from those countries where such cloning is
legal, since the U.S. ban would have no direct impact there. Indeed, the generally more
liberal attitude toward embryo research in the United Kingdom as compared to the United
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Supreme Court has said, a state may not "prohibit possession of chemistry
books on the ground that they may lead to the manufacture of homemade
spirits. ' ' 2' It is no great feat to write legislation that bans reproductive
cloning while allowing therapeutic cloning; indeed, some states have
passed laws that do just that. If our society remains committed to
prohibiting reproductive cloning, it can prohibit it without stamping out
therapeutic cloning as well.
The other justification for banning therapeutic cloning turns on the
status of the stem cells that are used in the process. For many Americans,
these cells represent either human life or potential human life.31 For those
with this view, banning therapeutic cloning is identical or similar to
banning research on human subjects.3 It does not matter that such
research could lead to medical breakthroughs.3 Our respect for human
personhood is such that we require consent before we do research on
people.3 4 Since no consent is possible from embryonic stem cells and since
the cells may be destroyed as part of the research process, these critics
argue that therapeutic cloning should be banned.35
As I just indicated, this objection rests on the belief that embryonic
stem cells are entitled to the protections we extend to life or potential life.
The most immediate problem with this argument is that it does not reflect
societal or legal attitudes, even in the states that have banned therapeutic
cloning. As many observers have pointed out, there is an enormous
contradiction between the concerns about therapeutic cloning and the
29. Stanley v. Georgia, 394 U.S. 557, 567 (1968) (holding that the state may not
prohibit possession of obscene materials on the ground that such possession may lead to
antisocial conduct).
30. See, e.g., CAL. HEALTH & SAFETY CODE §§ 24185-24187 (Deering 2003); R.I. GEN.
LAWs §§ 23-16.4-1 to 23-16.4-3 (2001); see also John A. Robertson, Two Models of Human
Cloning, 27 HOFSTRA L. REv. 609, 614 (1999); R. Alta Charo, The Ethics of Control, 2 YALEJ.
HEALTH POL'Y L. & ETHICS 143, 155 n.45 (2001). See generally States Show Washington the Way
To Go on Stem Cells, NEWSDAY, March 19, 2003, at A28.
31. See generally Consuelo G. Erwin, Note, Embryonic Stem Cell Research: One Small Step for
Science or One Giant Leap Back for Mankind?, 2003 U. ILL. L. REv. 211; Clarke D. Forsythe,
Legal Perspectives on Cloning: Human Cloning and the Constitution, 32 VAL. U. L. REV. 469
(1998).
32. Id.
33. See supra note 10.
34. See, e. g., MICHAEL H. SHAPIRO ET AL., BIOETHICS AND LAW: CASES, MATERIALS AND
PROBLEMS 198-231 (2003).
35. See, e.g., Erwid, supra note 31; Forsythe, supra note 31.
7
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broad acceptance of assisted reproductive technologies)" In hundreds of
clinics across the United States, would-be parents use in vitro fertilization
techniques in which sperm and egg are brought together outside of the
womb, and numerous embryos are created, only some of which are then
implanted and brought to term.
The disposition of the "spare embryos" that almost invariably result
from in vitro fertilization illustrates that they are not treated as human life
or potential human life. They are often destroyed, either because that is
the wish of the would-be parents, or because, in cases where the parents'
desires are unknown, the fertility clinic destroys them)8 In many cases, they
are frozen alive through a process called cryopreservation, and their
ultimate fate is uncertain.39
One might argue that therapeutic cloning is more objectionable than
in vitro fertilization because the former creates embryos with the intention
of destroying them after the research is completed. In the case of fertility
clinics, however, the goal is to create human life, and the creation of spare
embryos is only an unfortunate byproduct of that goal. In other words, it
might strike some people as worse to create an embryo explicitly for
40medical research purposes.
There are a number of problems with this distinction. First, it is
perfectly predictable that spare embryos will result from fertility
treatments, so the demise of these embryos is not at all surprising.4'
Secondly, in vitro fertilization is not always successful. 4 Thus, the argument
reduces to the belief that destroying several embryos is acceptable in the
hope of producing healthy life. But if that is so, it would seem to justify
therapeutic cloning, as well; there, too, embryos are destroyed, but it is
with the goal of producing healthy life. Indeed, if therapeutic cloning lives
up to its promise, it may save countless lives, both embryonic and full-
36. See, e.g., Rhodes, supra note 7, at 349; Sandel, supra note 10.
37. See, e.g., SHAPIRO ET AL., supra note 34, at 625-41.
38. Id.
39. Mailee R. Harris, Stem Cells and the States: Promulgating Constitutional Bans on
Embiyonic Experimentation, 37 VAL. U. L. REv. 243, 244-45 (2003).
40. Sandel, supra note 10.
41. Harris, supra note 39.
42. The national average for pregnancy rates from in vitro fertilization is estimated to be
thirty percent. See Amy Dockser Marcus, Treatments Work To Reduce Risky Multiple Births,
HOUSTON CHRON., Feb. 23, 2003, at A4. Even with the most advanced screening techniques,
the success rate for in vitro fertilization for women over thirty-eight does not exceed fifty
percent. Carey Goldberg, Screening of Embryos Helps Avert Miscarriage, BOSTON GLOBE, June
13, 2003, at Al.
IV:2 (2004)
8




It is important to note that not all spare embryos from fertility clinics
are destroyed; some have been used to create stem cell lines that are used
for scientific research." In August 2001, after much deliberation and
publicity, President Bush announced that federal funding would be
allowed for research on existing stem cell lines, but not for new lines
created from spare embryos after the date of his announcement. 45 The
President, because he gave weight to the view that embryos are potential
life, did not want to encourage the creation of stem cell lines for research
purposes.46 However, by only withholding federal funding, he permitted
such research to continue, so long as private funding is available. And stem
cell research on non-cloned embryos has, in fact, continued since
President Bush's announcement. On March 3, 2004, Harvard researchers
announced that they had used private funding to create seventeen new
stem cell lines for research purposes, more than doubling the world's
available supply.4 7 Eleven million dollars in private funding is supporting
similar research at the University of California at San Francisco, while
Harvard plans to raise one hundred million dollars to continue its efforts.48
Thus, the inconsistency between the effort to ban therapeutic cloning
and the acceptance of privately funded stem cell research on non-cloned
embryos is clear. The proposed federal legislation criminalizes not only the
importation of any medicine produced by human cloning anywhere in the
world, 49 but also research on cloned human embryos no matter whether
privately or publicly funded. ° Why should it be a crime to use your own
money to do stem cell research on cloned embryos, but perfectly lawful to
use your own money to do stem cell research on spare embryos from
fertility clinics?
This question reveals what really is at stake here: Cloning matters. It is
opposition to cloning that fuels the drive to criminalize promising science.
It is not a concern for potential life, as some opponents of such research
43. Sandel, supra note 10.
44. See Rick Weiss & Justin Gillis, New Embryonic Stem Cells Made Available, WASH. POST,
March 4, 2004, at A02 (discussing the creation of stem cell lines from human embryos
donated by a fertility clinic).
45. For a transcript of President Bush's speech on stem cell research, see The President's
Decision, N.Y. TIMES, Aug. 10, 2001, at Al6.
46. Id.
47. Weiss & Gillis, supra note 44.
48. Id.
49. See supra note 3.
50. See supra note 2.
9
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suggest. How could that be the reason, when we know that the law permits
research on spare embryos, which represent as much potential for life as
cloned embryos? Cloning matters; and, in an important sense, this has
been clear from the beginning of the debate about therapeutic cloning.
III. CLONING MATTERS AND THE LAWRENCE RESPONSE
Leon R. Kass, the Chairman of the President's Council on Bioethics, is
the most articulate opponent of all forms of human cloning. He grounds
his opposition in the "repugnance" that so many feel toward cloning, and
he argues that "repugnance is the emotional expression of deep wisdom,
beyond reason's power fully to articulate it.''" He observes that most
opponents of human cloning describe it as "Offensive. Grotesque.
Revolting. Repugnant. Repulsive."52 He extends his criticism to both
reproductive and therapeutic cloning.
53
Kass has voiced an important truth: Many share a profound feeling
that cloning an embryo is unnatural and unsettling. In opposing both
therapeutic and reproductive cloning, one member of the House of
Representatives called them "ghoulish, '' 4 while a Bush Administration
official called them "repugnant.
' 5
But is repugnance alone an adequate basis for a governmental ban on
medicines derived from therapeutic cloning? The Supreme Court's recent
decision in Lawrence v.- Texas suggests that it is not. In Lawrence, the Court
struck down a Texas law that criminalized homosexual sodomy. 56 As was
widely noted, Justice Kennedy's opinion for the Court affirmed the liberty
interest all individuals have in engaging in intimate sexual conduct.57 Less
widely noted, but equally important, was the respect the Court's opinion
showed for those who oppose homosexuality. The Court did not trivialize
51. Leon R. Kass, The Wisdom of Repugnance: Why We Should Ban the Cloning of Humans, 32
VAL. U. L. REv. 679, 687 (1998). Kass submitted these views to a congressional subcommittee
considering cloning legislation. See Cloning: Legal, Medical, Ethical, and Social Issues: Hearing
Before the House Subcomm. on Health and Environment of the Comm. on Commerce, 105th Cong.
119 (1998).
52. Kass, supra note 51, at 686 (internal quotation marks omitted).
53. Id. at 685-86.
54. The Good Kind of Cloning, L.A. TIMES, March 12, 2003, at 2-12 (quoting Rep. Sue
Wilkins Myrick).
55. Richard Willing, U.N. Plan Would Ban Cloning To Create Human Baby, USA TODAY,
Sept. 23, 2002, at A3 (quoting legal adviser to the U.S. U.N. mission Carolyn Willson).
56. Lawrence v. Texas, 123 S. Ct. 2472 (2003).
57. Id. at 2484.
IV:2 (2004)
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their concerns, but argued instead that feelings of repugnance toward a
practice, even when shared by a majority of the community, cannot
overcome the beliefs of the minority:
The condemnation [of homosexuality] has been shaped by religious
beliefs, conceptions of right and acceptable behavior, and respect for the
traditional family. For many persons these are not trivial concerns but
profound and deep convictions accepted as ethical and moral principles
to which they aspire and which thus determine the course of their lives.
These considerations do not answer the question before us, however.
The issue is whether the majority may use the power of the State to
enforce these views on the whole society through operation of the
criminal law. 5s
Of course, there are differences between the issues decided in
Lawrence and the ones at stake in the debate about cloning. But the
similarities are striking: Prohibiting a ban on therapeutic cloning shows no
disrespect to the views of those who find cloning profoundly unnatural;
such a ban simply says that those views alone cannot provide the rational
basis necessary to justify a criminal ban on therapies that may save lives.
The similarities extend to Justice O'Connor's concurrence in Lawrence.
O'Connor did not agree with the five Justices who joined the Court's
opinion which held that Texas had violated the liberty interests of gays. 59
But she found the Texas statute unconstitutional on other grounds.
O'Connor noted that in Texas sodomy was a crime if engaged in by same-
sex couples, but was perfectly legal when engaged in by opposite-sex
partners. She found that such an irrational distinction violated the Equal
Protection Clause. ° It is noteworthy that O'Connor did not rely on equal
protection cases in which the Court applied strict scrutiny to legislation
creating racial distinctions.1 She simply applied the more deferential
"rational basis review" applicable when "challenged legislation inhibits
personal relationships, '6 2 yet, even under this deferential standard, she
found the statute unconstitutional.
Here again, while there are differences between the two situations,
58. Id. at 2480.
59. Id. at 2484 (O'ConnorJ, concurring in the judgment).
60. Id. at 2484-88 (O'ConnorJ, concurring in the judgment).
61. See, e.g., McLaughlin v. Florida, 379 U.S. 184, 191-92 (1964) (contrasting the
deference accorded to ordinary legislative classifications with the far more demanding
"strict scrutiny" of racial classifications).
62. Lawrence v. Texas, 123 S. Ct. 2472, 2485 (O'Connor, J., concurring in the
judgment).
11
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there is a remarkable parallel with the cloning dispute. Imagine two
patients: one who would benefit from a drug that came from research on
spare embryos and another who wanted to use a drug that came from
research on cloned embryos. Why should the first be free to take the
medicine while the second one goes to jail? Once more, Lawrence suggests
that repugnance at cloning is not an adequate answer.
This still does not exhaust the similarities between Lawrence and the
cloning dispute. In Lawrence, for example, the Court's opinion found it
significant that other countries did not criminalize the sexual conduct at
issue, and Texas had not shown that it had an interest that was "somehow
more legitimate or urgent. 6 3 The same point might be made about
therapeutic cloning, where research proceeding overseas may lead to
treatments, and the United States has not demonstrated why it has an
urgent need to prevent its citizens from receiving such treatments.6
Lawrence did not come out of nowhere. In 1996, the Supreme Court, in
Romer v. Evans, struck down an amendment to the Colorado constitution
that prohibited all governmental action designed to protect gays from
65discrimination. Justice Kennedy's opinion for the Court said this
amendment could be upheld if it simply bore "a rational relation to some
legitimate end,"66 but the amendment failed even that modest test because
it was "inexplicable by anything but animus" toward gays.6' As Lawrence
demonstrates, repugnance is no better ajustification.
TV. CONCLUSION
The United States government, at both the federal and state level,
faces a choice: It can ban therapeutic cloning, or it can allow it to proceed.
A ban is an unwise policy of doubtful constitutionality. Preventing the
development and importation of medicine derived from therapeutic
cloning does not serve valid policy goals. Rather, it is based on a sense of
63. Id. at 2483.
64. On the regulation of therapeutic cloning abroad, see Rhodes, supra note 7. Rhodes
notes that the United Kingdom and Japan allow therapeutic cloning, while Germany avoids
the inconsistency in American policy by banning all genetic research on embryos. Id. at 351-
55.
65. Romer v. Evans, 517 U.S. 620 (1996).
66. Id. at 631.
67. Id. at 632. The failure of the Colorado amendment to survive the deferential
rational basis test was unusual, but not unprecedented. See Robert C. Farrell, Successful
Rational Basis Claims in the Supreme Court from the 1971 Term Through Romer v. Evans, 32 IND.
L. REv. 357 (1999).
IV:2 (2004)
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repugnance that should not drive public policy. Thus, therapeutic cloning
should be allowed in the United States.
Allowing therapeutic cloning does not necessitate allowing
reproductive cloning. Patients seeking medical treatment may be limited
in their search if the treatment is not safe or effective. Reproductive
cloning can be banned for this reason. But a ban on therapeutic research
before we know whether it will lead to safe and effective therapies, and a
ban on importing medicines derived from therapeutic cloning even if such
medicines are safe and effective, cannot be justified on this ground.
Indeed, virtually any form of scientific and medical research can be turned
to unlawful ends, but no one seriously believes that we should abandon
science and medicine as a result.
Additionally, therapeutic cloning cannot be banned because of the
status of the cloned embryos that are involved. We allow private research
on non-cloned embryos that are a by-product of routine in vitro
fertilization; in fact, we even allow such non-cloned embryos to be
destroyed. It is irrational to treat cloned embryos differently.
It is not surprising that these arguments for banning therapeutic
cloning are unpersuasive. They are unpersuasive because they conceal the
central reason why opponents condemn cloning: They find it repugnant.
However heartfelt that feeling is, it cannot serve as a legitimate basis for
criminal statutes that deprive patients of the opportunity to receive
potentially life-saving medicines. Our courts have allowed patients access to
pain relief that hastens death and to controversial abortion procedures
despite public opposition. As Lawrence demonstrates, repugnance alone
cannot provide a rational basis for legal distinctions that harm individuals.
Cloning matters. It matters in the sense that it explains the motivation
behind the proposed bans. But it also matters in the sense that therapeutic
cloning is a promising avenue to innovative treatments for serious diseases.
This avenue should not be blocked before its true value as a research tool
can be conclusively determined.
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